The DCLRE1B gene helps cells repair certain DNA damage and protect the ends of chromosomes, called telomeres, during cell division. If this gene does not work properly, cells may become unstable or stop dividing too soon. People with harmful variants in the DCLRE1B gene can develop a telomere biology condition, often with poor growth, low blood counts from bone marrow failure, immune problems, and sometimes features of dyskeratosis congenita or Hoyeraal-Hreidarsson syndrome.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Others mainly help control when certain processes take place, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
DCLRE1BGene function
What if the gene works
The DCLRE1B gene helps cells repair damaged DNA and protect chromosome ends. This supports stable cell division, especially in tissues that renew often.
Risk
What if the gene does not work
More disruptive variants in the DCLRE1B gene can cause a telomere biology condition, often with growth problems, bone marrow failure, immune weakness, and features of dyskeratosis congenita or Hoyeraal-Hreidarsson syndrome. Milder variants may lead to later onset or fewer features.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the DCLRE1B gene do not currently have an established, gene-specific treatment or drug selection approach. Research is exploring the DCLRE1B gene in DNA repair and cell aging, including whether it may help predict response to some cancer treatments.
Gene function
What if the gene works
Each time a cell copies its DNA, it also has to tidy and protect the ends of its chromosomes. The DCLRE1B gene function is especially important here, helping cells keep these ends stable and helping with certain kinds of DNA repair. This steady upkeep supports normal cell division across many tissues.
DCLRE1B helps process telomeres, the protective caps at the ends of chromosomes, after DNA is copied. This shaping step helps the cell form a stable natural end rather than treating it like broken DNA.
Its protein works closely with other telomere proteins to shield chromosome tips during normal cell division. That protection helps keep chromosome ends organized and reduces unnecessary DNA damage alarms.
Inside your cells, DCLRE1B also helps handle certain forms of DNA damage, especially damage that links the two DNA strands together. This supports accurate DNA repair as cells grow, copy their DNA, and respond to everyday stress.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no visible effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
DCLRE1B gene variants can weaken the Apollo protein by reducing its cutting activity, making it less stable, or disrupting its contact with proteins that guard chromosome ends. Some changes leave partial function, while more severe variants can sharply lower protein activity or stop production altogether, leading to more telomere damage and less effective DNA repair. In telomere biology conditions linked to the DCLRE1B gene, this severity range can influence how early features appear and how strongly they affect the body.
How variants are linked to conditions
Pathogenic variants in the DCLRE1B gene can cause rare telomere biology conditions, most notably Hoyeraal-Hreidarsson syndrome and related forms of dyskeratosis congenita. In this setting, DCLRE1B gene variants linked to conditions are usually identified in people with symptoms starting in childhood, and a confirmed pathogenic variant can support or establish the diagnosis. These conditions may include bone marrow failure, poor growth, immune system problems, and developmental differences.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are common throughout the general population. Most have no direct effect on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the DCLRE1B gene. For many living with a disease-causing DCLRE1B change, risk is mainly linked to the inherited variant itself rather than everyday lifestyle factors, so personal guidance from a doctor or genetic counselor is important.
Inheritance of DCLRE1B variants
For families asking how DCLRE1B gene variants are inherited, the well-established pattern is autosomal recessive. This means a child usually inherits one altered copy of the DCLRE1B gene from each parent, while the parents are often healthy carriers. When both parents carry a disease-causing variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. Because the DCLRE1B gene is on an autosome, this pattern is the same for males and females.
What does my DCLRE1B result mean for my family?
A disease-causing result in the DCLRE1B gene is most often linked to a recessive condition, which means close relatives may be healthy carriers without knowing it. Brothers and sisters could also be carriers or, in some families, may also be affected. For family members, the main question is usually whether they carry the same gene change, especially when planning a family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, DCLRE1B genetic testing uses a blood or saliva sample to read the DCLRE1B gene. The lab compares your gene sequence with a reference and reports whether it finds a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing may be considered if doctors suspect an inherited telomere condition, especially in someone with very low blood counts, repeated infections, poor growth, or a family history of early bone marrow failure. Testing for the DCLRE1B gene can help confirm the cause in some families.
A genetic result is only one part of your health story
A genetic result can be informative, but what it reveals depends on the condition and the specific type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes affect the way people respond to medications. It examines relationships between genes and drugs to help explain why the same treatment can work differently in different people. With many medicines, genes can influence either how strongly a drug works or how the body handles it. This understanding can support treatment decisions that are both more informed and more personalized. To explore this subject further, more information is available in the LearnHub.
Drugs influenced by the DCLRE1B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor. Seek advice promptly if a new medicine causes unexpected symptoms or is not helping as expected.
History
Research on the DCLRE1B gene emerged in the early 2000s during efforts to map human genes involved in DNA damage responses. It was first studied under the name SNM1B because it resembled genes already known from yeast experiments. Soon after, the same gene was also described as Apollo in telomere research, reflecting how different labs approached the same discovery from different angles. Scientific classifications changed as researchers learned more about the gene. By the late 2000s, these lines of research had been brought together, and DCLRE1B became the standard name used in human genetics. Its history is mainly scientific rather than public, shaped by steady lab discoveries rather than a single high-profile event.